CDDO-Im (Synonyms: RTA-403; TP-235; CDDO-Imidazolide)
目录号: PL04511 纯度: ≥98%
CAS No. :443104-02-7
商品编号 规格 价格 会员价 是否有货 数量
PL04511-2mg 2mg ¥1236.36 请登录
PL04511-5mg 5mg ¥1854.55 请登录
PL04511-10mg 10mg ¥2720.00 请登录
PL04511-50mg 50mg 询价 询价
PL04511-100mg 100mg 询价 询价
PL04511-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2210.62 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
CDDO-Im
中文别名
CDDO咪唑
英文名称
CDDO-Im
英文别名
CDDO Imidazolide;(4aR,6aR,6aS,6bR,8aS,12aS,14bS)-8a-(imidazole-1-carbonyl)-4,4,6a,6b,11,11,14b-heptamethyl-3,13-dioxo-4a,5,6,6a,7,8,9,10,12,12a-decahydropicene-2-carbonitrile;CDDO Im;TP 235;CDDO-Im;CDDO-Imidazolide;RTA-403;TP-235
Cas No.
443104-02-7
分子式
C34H43N3O3
分子量
541.72
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
CDDO-Im (RTA-403) 是 Nrf2 和 PPAR 的活化剂,对 PPARα 和 PPARγ 的 Ki 分别为232 nM 和 344 nM。
生物活性
CDDO-Im (RTA-403) is an activator of Nrf2 and PPAR, with K i s of 232 and 344 nM for PPARα and PPARγ.
性状
Solid
IC50 & Target[1][2]
PPARα 232 nM (Ki) PPARγ 344 nM (Ki)
体外研究(In Vitro)
CDDO-Im is highly active in suppressing cellular proliferation of human leukemia and breast cancer cell lines (IC50 approximately 10-30 nM). In U937 leukemia cells, CDDO-Im also induces monocytic differentiation as measured by increased cell surface expression of CD11b and CD36. Treatment with CDDO-Im elevates protein levels of Nrf2, a transcription factor previously shown to bind ARE sequences, and increases expression of a number of antioxidant and detoxification genes regulated by Nrf2. CDDO-Im is one of the most potent synthetic triterpenoids shown to induce growth inhibition and apoptosis in various human cancer cells, including multiple myeloma, lung, pancreas and breast cancer. CDDO-Im treatment markedly induces cell cycle arrest at G2/M-phase and apoptosis in the triple-negative breast cancer cell lines, SUM159 and MDA-MB-231. The CD24?/EpCAM+ cells in SUM15
体内研究(In Vivo)
CDDO-Im is a potent inhibitor of de novo inducible nitric oxide synthase expression in primary mouse macrophages. Moreover, CDDO-Im inhibits growth of B16 murine melanoma and L1210 murine leukemia cells in vivo. Injection of 10 nM (5.4 μg) of CDDO-Im almost completely blocks the ability of IFN-γ to induce iNOS, and treatment with as little as 1 nmol of CDDO-Im (0.54 μg) is partially effective. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Place AE, et al. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin Cancer Res. 2003 Jul;9(7):2798-806.
[2]. Liby K, et al. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 2005 Jun 1;65(11):4789-98.
溶解度数据
In Vitro: DMSO : 25 mg/mL (46.15 mM; ultrasonic and warming and heat to 60°C)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2